Collectively, the MAPK/NF-κB pathway integrates Aβ/tau toxicity, oxidative stress, and cytokine networks, serving as a pivotal hub in AD neuroinflammation and representing a promising therapeutic target. Here, NFKB1 is linked to Alzheimer disease.